Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia

Annals of Hematology

Volumn 88, Issue 7, 2009, Pages 653-657

  Takaku, Tomoiku ^a   Calado, Rodrigo T ^a   Kajigaya, Sachiko ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Aplastic anemia; Autoimmune disease; IL 23R; Polymorphism

Indexed keywords

ARGININE; ASPARAGINE; GLUTAMINE; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; ISOLEUCINE; THREONINE; VALINE;

APLASTIC ANEMIA; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANEMIA, APLASTIC; AUTOIMMUNITY; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-23; MALE; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN;

EID: 66149100603     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0666-6     Document Type: Article

References (32)

1. Baechler EC, Gregersen PK, Behrens TW (2004) The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 16:801-807 doi: 10.1016/j.coi.2004.09.014
2. Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J, Hauser SL, Oksenberg JR (2007) The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 68:934-937 doi: 10.1016/j.humimm.2007.09.005
3. Bettelli E, Oukka M, Kuchroo V (2007) Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345-350 doi: 10.1038/ni0407-345
4. Büning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, Bühner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Büttner J, Lochs H, Witt H (2007) Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther 26:1025-1033
5. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abkevic V, Burden AD, Lanchbury J, Barker JN, Trembath RC, Nestle FO (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201-206 doi: 10.1007/s00439-007-0397-0
6. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273-290 doi: 10.1086/511051
7. Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A, Dutridge D, Wahbeh G, Silber G, Bahar R, Mengesha E, Targan SR, Taylor KD, Rotter JI (2007) IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis 13:511-515 doi: 10.1002/ibd.20126
8. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-1463 doi: 10.1126/science.1135245
9. Giannakoulas NC, Karakantza M, Theodorou GL, Pagoni M, Galanopoulos A, Kakagianni T, Kouraklis-Symeonidis A, Matsouka P, Maniatis A, Zoumbos NC (2004) Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anemia patients. Br J Haematol 124:97-105 doi: 10.1046/j.1365-2141.2003.04729.x
10. Glas J, Seiderer J, Wetzke M, Konrad A, Török HP, Schmechel S, Tonenchi L, Grassl C, Dambacher J, Pfennig S, Maier K, Griga T, Klein W, Epplen JT, Schiemann U, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Folwaczny M, Mussack T, Brand S (2007) rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: Combined analysis of IL23R, CARD15, and OCTN1/ 2 variants. PLoS One 2:e819 doi: 10.1371/journal.pone.0000819
11. Ivanov II, Zhou L, Littman DR (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19:409-417 doi: 10.1016/ j.smim.2007.10.011
12. Kolls JK, Lindén A (2004) Interleukin-17 family members and inflammation. Immunity 12:467-476 doi: 10.1016/j.immuni.2004.08.018
13. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233-240 doi: 10.1084/jem.20041257
14. Libioulle C, Louis E, Hansoul S et al (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 3:e58 doi: 10.1371/ journal.pgen.0030058
15. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D, Vermeire S, Dewit O, de Vos M, Dixon A, Demarche B, Gut I, Heath S, Foglio M, Liang L, Laukens D, Mni M, Zelenika D, Van Gossum A, Rutgeerts P, Belaiche J, Lathrop M, Georges M (2007) Replication of an association between IL23R gene polymorphism with inflammatory bowel disease. Clin Gastroenterol Hepatol 5:977-981 doi: 10.1016/j.cgh.2007.05.002
16. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725 doi: 10.1016/S1074-7613(00)00070-4
17. Orozco G, Rueda B, Robledo G, García A, Martín J (2007) Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort. Hum Immunol 68:681-684 doi: 10.1016/j.humimm.2007.05.008
18. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A, Eckert A, Puri V, Gerhard DS, Chanock SJ (2006) SNP500-Cancer: A public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 32:D528-D532 doi: 10.1093/nar/gkh005
19. Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, Barclay ML, Kennedy MA (2007) IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 102:2754-2761 doi: 10.1111/ j.1572-0241.2007.01525.x
20. Ronnblom L, Eloranta ML, Alm GV (2006) The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 54:408-420 doi: 10.1002/ art.21571
21. Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, González-Gay MA, Martin J (2008) The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 67:1451-1454
22. Sánchez E, Rueda B, Callejas JL, Sabio JM, Ortego-Centeno N, Jimenez-Alonso J, López-Nevot MA, Martín J (2007) Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens 70:233-237 doi: 10.1111/ j.1399-0039.2007.00881.x
23. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100:1185-1191 doi: 10.1182/ blood-2002-01-0035
24. Solomou EE, Keyvanfar K, Young NS (2006) T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 107:3983-3991 doi: 10.1182/blood-2005-10-4201
25. Solomou EE, Rezvani K, Mielke S, Malide D, Keyvanfar K, Visconte V, Kajigaya S, Barrett AJ, Young NS (2007) Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood 110:1603-1606 doi: 10.1182/blood-2007-01-066258
26. Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ, Sanderson J, Bredin F, Berzuini C, Forbes A, Lewis CM, Cardon L, Deloukas P, Jewell D, Mathew CG, Parkes M, Satsangi J (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132:1657-1664 doi: 10.1053/j.gastro.2007.02.051
27. Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimetric cytokines: New players in the regulation of T-cell responses. Immunity 19:641-644 doi: 10.1016/S1074-7613(03)00296-6
28. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cua DJ, Powrie F (2006) Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309-318 doi: 10.1016/j.immuni.2006.05.017
29. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Davies G, Anderson NH, Gillett PM, McGrogan P, Hassan K, Weaver L, Bisset WM, Mahdi G, Wilson DC, Satsangi J (2007) IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 56:1173-1174 doi: 10.1136/gut.2007.122069
30. Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372 doi: 10.1056/NEJM199705083361906
31. Young NS, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:2509-2519 doi: 10.1182/blood-2006-03-010777
32. Zhang Z, Hinrichs DJ, Lu H, Chen H, Zhong W, Kolls JK (2007) After interleukin-12p40, are interleukin-23 and interleukin 17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 7:409-416 doi: 10.1016/j.intimp.2006.09.024